LinkOPH

Iordanis Chatziangelidis, a young ophthalmologist training in Athens, tells us about his efforts to improve the cataract surgery experience for patients, and possibly help the surgeon, too. Using established technology in a new way, the patient watches…

Read more →

Performing immediately sequential bilateral cataract surgery, or ISBCS, as opposed to scheduling two separate surgery days, continues to gain popularity, due mostly to patient convenience and cost savings. However, the safety of same-day surgery is still a lingering concern to some, as are suboptimal visual outcomes. U.S. surgeons also point out unjust compensation: Treating the second eye on the same day is reimbursed at only 50% of the first eye.The 2011 Preferred Practice Patterns (PPP) from the American Academy of Ophthalmology for cataract in the adult eye notes that most (Read more...)

After completing an initial public offering in July 2014, Ocular Therapeutix is prepared to forge ahead with research and development and execute plans to market novel drug delivery products from the platform that is the company’s hallmark.Although some losses related to research and development are expected, the company plans to devote newly available capital to drive innovation and carve new therapeutic niches in ophthalmology.

Read more →

Alimera Sciences will host a live webinar for eye care professionals to help launch Iluvien for the treatment of diabetic macular edema, according to a press release.“We chose this novel webinar launch approach in order to disseminate information about Iluvien to [the retinal community] as efficiently and effectively as possible. It is our hope that by providing this open discussion platform, physicians will feel empowered to take advantage of this cutting-edge treatment option and make it quickly available to their appropriate DME patients,” Dan Myers, president and CEO of Alimera, (Read more...)